Approval · Notice of Compliance 2250 · 2001
FLONASE: Notice of Compliance 2250
Issued November 19, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2250
- Date
- November 19, 2001
- Company
- Glaxosmithkline IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication: management of sinus pain and pressure associated with allergic rhinitis
- Therapeutic class
- Corticosteroid for nasal use
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FLONASE | Not yet assigned | — |
Medicinal ingredients
- FLUTICASONE PROPIONATE 50 MCG per ACT